World's Best Scientists 2026 revealed!
Randy D. Gascoyne

Randy D. Gascoyne

Award Badge
Best Scientists
2025
Award Badge
Medicine
Canada
2026

D-Index & Metrics

Best Scientists

D-Index
174
Citations
134697
World Ranking
738
National Ranking
16

Medicine

D-Index
175
Citations
140512
World Ranking
423
National Ranking
9

Research.com Recognitions

  • 2026 - Research.com Medicine in Canada Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Canada Leader Award
  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Randy D. Gascoyne is affiliated with the BC Cancer Agency in Canada. Their main field of study is Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology, and Neurology.

The research topics that dominate their work include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Genetic factors in colorectal cancer

Gascoyne's recent publications showcase contributions to lymphoma and related hematologic malignancies. Key papers include:

  • "ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma", 2021, Journal of Clinical Oncology
  • "Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population", 2022, Blood
  • "MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma", 2021, Haematologica
  • "TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma", 2020, Nature Medicine
  • "Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing", 2020, Blood

Frequent collaborators in their work include:

  • David W. Scott
  • Graham W. Slack
  • Kerry J. Savage
  • Diego Villa
  • Joseph M. Connors

Their work has appeared primarily in the following publication venues:

  • Blood
  • Blood Advances
  • UNC Libraries
  • Haematologica
  • Journal of Clinical Oncology

Best Publications

  • Circos: An information aesthetic for comparative genomics

    Martin I Krzywinski;Jacqueline E Schein;Inanc Birol;Joseph Connors

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

    Morin Rd;Johnson Na;Severson Tm;Mungall Aj

  • Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

    Ryan D Morin;María Méndez-Lago;Andrew J Mungall;Rodrigo Goya

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

    Thomas M. Habermann;Edie A. Weller;Vicki A. Morrison;Randy D. Gascoyne

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

    Laurie H. Sehn;Brian Berry;Mukesh Chhanabhai;Catherine Fitzgerald

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Non-Hodgkin lymphoma.

    James O Armitage;Randy D Gascoyne;Matthew A Lunning;Franco Cavalli

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

    Laurie H. Sehn;Jane Donaldson;Mukesh Chhanabhai;Catherine Fitzgerald

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project

    Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich

Frequent Co-Authors

Joseph M. Connors
Joseph M. Connors University of British Columbia
Christian Steidl
Christian Steidl University of British Columbia
Kerry J. Savage
Kerry J. Savage University of British Columbia
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Elias Campo
Elias Campo University of Barcelona
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Marco A. Marra
Marco A. Marra University of British Columbia
Ryan D. Morin
Ryan D. Morin Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical education in the USA can open up a wide range of related careers in healthcare. Many students consider alternative and complementary online degrees to diversify their career options or advance in medical and healthcare fields.

For nurses with a BSN, specialized roles are accessible through bsn to np programs online, which prepare graduates for advanced nursing practices, including psychiatric and mental health specializations.

Those interested in healthcare management or policy may pursue a cheapest online health science degree or target the cheapest mha programs online to gain skills in administration and leadership within hospitals and clinics.

For nurses aspiring to the highest levels of clinical practice, the cheapest dnp online programs offer a pathway to a Doctor of Nursing Practice, enhancing opportunities in advanced patient care, education, and healthcare policy-making.

These online programs offer flexible, affordable routes to diverse healthcare careers that complement or extend traditional medical training in the USA.

Best Scientists Citing Randy D. Gascoyne

Trending Scientists

Recently Published Articles